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although the timing of the clinical presentation makes this
less likely.
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Case  reports  and  misdiagnosi
Informe  de  casos  de  acidosis  tubu
Dear Editor,
Renal tubular acidosis (RTA) is a pathophysiological alteration
of acid–base metabolism, characterised by the presence o
hyperchloraemic metabolic acidosis, which is caused by rena
loss of bicarbonate or a reduction in hydrogen ion excre
tion by the renal tubules.1 A suspicion of RTA is based on
the clinical presentation of various signs and symptoms such
as anorexia, vomiting, polyuria, polydipsia, delayed growth
muscle weakness, rickets, nephrocalcinosis and sensorineu
ral deafness.2 The diagnosis is validated with laborator
examinations that should include the demonstration of hyper-
chloraemic metabolic acidosis, with a normal blood anion gap
and a blood pH lower than 7.35, in patients with decompen-
sated metabolic acidosis. In the case of secondary RTA, it is
important to diagnose the systemic disease that is causing
it.1 It should be noted that intestinal losses of bicarbon-
ate, whether they are due to diarrhoea or a ﬁstula, are a
common cause of the same acid–base alterations, and so
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they should not be present when a diagnosis of RTA i
made.
RTA has been reported to be overdiagnosed in Mexico,3,
and it has been associated with allergy.4–6 For this reason, we
conducted a study with the aim of documenting the diagnosi
of RTA in children from different hospitals. A total of 170 chil
dren with a prior diagnosis of RTA were enrolled; the majority
were receiving alkaline treatment. Treatment was suspended
5 to 7 days prior to the initial assessment, which consisted
of a medical history, laboratory examinations and an assess
ment by the allergy department. A diagnosis of RTA was onlyrnández HRG, Toussaint G, Pinto C, et al. Informe de casos de
3–325.
conﬁrmed in 3 patients (1.8%), one with distal RTA and 2 with
RTA secondary to cystinosis, which were accompanied by Fan-
coni syndrome. None of them had an allergy. The rest of the
patients’ prior diagnosis of RTA was erroneous; failure to thrive
was caused by other conditions such as nutritional deﬁciency,
Turner syndrome, giardiasis, coeliac disease, familial short
stature, hypophosphataemic rickets, coenzyme Q10 deﬁciency
or cardiomyopathy. The cases with RTA are described below.
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Case 1: A 12-year-old eutrophic female patient with nor-
mal  anthropometric measurements for her age and gender.
She was diagnosed with RTA at one month of age, and since
then she has been receiving a potassium citrate solution. On
the third day of suspending alkaline treatment she had vom-
iting, metabolic acidosis, blood pH 7.22; [HCO3−] 10 mmol/l;
blood anion gap 11; K+ 2.2 mEq/l; Cl− 114 mEq/l; urine cal-
cium/creatinine 1.38; urinary pH: 7.5. Alkaline treatment —
bicarbonate and potassium — was restarted. Kidney ultra-
sound: grade III medullary nephrocalcinosis. Molecular study:
mutation of the ATPV60A4 gene, not previously reported in the
literature, which shall be the subject of a subsequent publica-
tion.
Case 2: A 22-month-old male patient with delayed growth
since sixth months of age. At 11 months, he was diagnosed
with distal ATR, with vomiting, polydipsia and polyuria, and
he received treatment with a potassium citrate solution.
Entry into the study: weight 7.88 kg (p < 3); height 71 cm (p < 3);
weight/age 71%; weight/height 86.3%; height/age 91.8%; BMI
Z-score: −1.47. Blood gases pH 7.39; [HCO3−] 16.2 mmol/l; K+
3.0 mEq/l; HPO4− 2.4 mg/dl; urine pH: 7.5; trace albumin, +glu-
cosuria; microscopic haematuria, 45% tubular reabsorption of
phosphate. Administration of furosemide: did not have uri-
nary acidiﬁcation. Ophthalmology: birefringent crystals in the
cornea with a slit lamp. A diagnosis of infantile nephropathic
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87p13, NG 012489.1 RefSeqGene): compound heterozygous
notype, predictor of severe form of infantile nephropathic
stinosis with deletion of 57 kb, deletion of the ﬁrst 10 exons,
utation more  common in Caucasian, Mexican and Latin
merican patients7,8 with cystinosis and a minor deletion
reviously reported in European populations.9
eatment with cysteamine bitartrate, phosphates,
icarbonate and potassium, with satisfactory
olution.
Case 3: A 20-month-old female patient with polyuria,
olydipsia, anorexia and delayed growth. RTA was sus-
ected, and she was referred to our institution without being
eated. Weight 6.9 kg (p < 3); height 75.5 cm (p < 3); weight/age
.9%; weight/height 73%; height/age 91.3%. Blood gases: pH
47; [HCO3−] 13.8 mmol/l; K+ 3.6 mEq/l; HPO4− 2.2 mg/dl; Cl−
4 mEq/l; urine pH 7.0; glucosuria 100 mg/dl; +albumin. Oph-
almology: birefringent corneal cystine crystals. Molecular
udy of the CTNS gene: homozygous genotype, microdele-
on of exon 12, which deleted amino acids 346–349 of the
h transmembrane domain of cystinosin, which conﬁrmed
e diagnosis of infantile nephropathic cystinosis, reported
 Europeans10. Treatment with cysteamine bitartrate, phos-
hates, bicarbonate and potassium.
We  concluded that RTA is an uncommon tubulopathy, not
sociated with allergy, and conﬁrmed that it is overdiag-
osed in Mexico. We  recommend a comprehensive paediatric
proach in children with delayed growth, considering other
iseases in addition to RTA, with special caution in the studies
at are requested and their quality. When RTA is diagnosed,
e presence of primary diseases with secondary RTA shoulde ruled out, and suitable guidance and nutritional support
ould be provided.
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Creation  of  the Working  Group  on  Diagnostic  and
Interventional Nephrology  of  the Spanish  Society  of
Nephrology
Creación  del  Grupo  de  Trabajo  en  Nefrología  Diagnóstica  e
Intervencionista  de  la  Sociedad  Espan˜ola  de  Nefrología
Dear Editor,
At its meeting of 9 July 2014, the Board of Directors of the
Spanish Society of Nephrology (SEN) approved the creation
of the SEN Working Group on Diagnostic and Interventional
Nephrology (DIN). This letter, based on the group’s founding
document, which is available on the SEN website, aims to set
forth the reasons why it is necessary to create this group, its
objectives and its plan for action.
Ultrasound is an essential tool in the practice of medicine,
with multiple applications in kidney patients. In addition to
being a very informative and non-invasive diagnostic method,
it is the vehicle through which interventions such as biopsy on
the kidneys may be performed.1–5 Furthermore, it is crucial for
performing various interventions that are not strictly related
to the kidneys, but are the responsibility of the nephrologist,
such as placing central lines and managing arteriovenous ﬁs
tulas for haemodialysis.6 Finally, it allows the arteries to be
visualised for early diagnosis of subclinical artery disease, o
evolution of atheromatous disease, which is known to be the
basis of the majority of cardiovascular events and mortality
in the general population and to an even greater extent in the
kidney population.7
For this reason, it is important that the nephrologist learn
appropriate ultrasound techniques so as to perform and
interpret ultrasound examinations in order to achieve more
comprehensive and efﬁcient patient management.
Suitable and timely placement of the appropriate cathete
for peritoneal dialysis determines the prognosis for the patien
and the technique. The nephrologist is trained to place and
remove peritoneal catheters, and this is in fact what happen
in some Spanish departments of Nephrology. Please cite this article as: Rivera Gorrín M, Cornago Delgado I, Betr
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